Showing results (61-70 of 109) with videos related to
Sort By:
Pageof 11
Asian Journal of Endoscopic Surgery|April 21, 2025
Treatment Outcomes of Robotic Adrenalectomy Compared to Laparoscopic Adrenalectomy: A Propensity Score Matching StudyMiki Naito, Hiroyuki Shikuma, Tomoya Hatayama, et al.International Cancer Conference Journal|June 26, 2020
Renal metastasis from primary hepatocellular carcinoma: a case reportRyoken Yamanaka, Yohei Sekino, Takashi Babasaki, et al.Frontiers in Oncology|December 26, 2022
Complexity in radiological morphology predicts worse prognosis and is associated with an increase in proteasome component levels in clear cell renal cell carcinomaKohei Kobatake, Kenichiro Ikeda, Jun Teishima, et al.Oncology|June 26, 2020
TUBB3 Is Associated with High-Grade Histology, Poor Prognosis, p53 Expression, and Cancer Stem Cell Markers in Clear Cell Renal Cell CarcinomaYohei Sekino, Xiangrui Han, Takashi Babasaki, et al.The Prostate|April 22, 2026
Impact of the Nadir Androgen Receptor Signaling Inhibitor-Derived Integrative Response Model in Real-World Patients With Metastatic Castration-Sensitive Prostate CancerKazuma Yukihiro, Yohei Sekino, Keisuke Goto, et al.Urologic Oncology|March 27, 2021
TUBB3 is associated with PTEN, neuroendocrine differentiation, and castration resistance in prostate cancerYohei Sekino, Xiangrui Han, Takashi Babasaki, et al.Urologic Oncology|August 22, 2025
KDM6A deficiency promotes 5-aminolevulinic acid-mediated photodynamic therapy resistance in bladder cancer by suppressing ROS accumulationRyo Tasaka, Kohei Kobatake, Yuki Kohada, et al.Surgical Endoscopy|January 6, 2026
Intraoperative real-time display of 3D reconstruction models in robot-assisted partial nephrectomyShunsuke Miyamoto, Hiroyuki Shikuma, Ryo Tasaka, et al.Cancer Medicine|February 26, 2026
KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell CarcinomaYoshinori Nakano, Yohei Sekino, Go Kobayashi, et al.Urology Journal|August 27, 2023
The Efficacy of Neoadjuvant Gemcitabine and Cisplatin Chemotherapy for cT3N0M0 Upper Tract Urothelial Carcinoma: The Impact of Tumor LocationYuki Kohada, Tetsutaro Hayashi, Kenshiro Takemoto, et al.Pageof 11